In reply-Vascular Event Risk After Herpes Zoster
Mayo Clin Proc
.
2019 Aug;94(8):1650-1651.
doi: 10.1016/j.mayocp.2019.05.028.
Authors
Brandon J Patterson
1
,
Debora A Rausch
2
,
Debra E Irwin
3
,
Barbara P Yawn
4
Affiliations
1
U.S. Health Outcomes & Epidemiology, GSK, Philadelphia, PA.
2
Medical Affairs, GSK, Philadelphia, PA.
3
Outcomes Research, Truven Health Analytics, an IBM Company, Durham, NC.
4
Department of Family Medicine and Community Health, University of Minnesota, Minneapolis.
PMID:
31378245
DOI:
10.1016/j.mayocp.2019.05.028
No abstract available
Publication types
Letter
Comment
MeSH terms
Herpes Zoster*
Herpesvirus 3, Human
Humans